Executive Summary
The project "Moroccan Drug Health" Platform (MediMorocco AI): An Integrated Smart System for Pharmaceutical Supply Chain Management and Monitoring in Morocco, Connecting Pharmaceutical Companies, Distributors, Pharmacies, and Hospitals in the medical and health sector in Morocco targets a promising market opportunity. With an investment of ٣,٥٠٠,٠٠٠ د.م, it achieves a net present value (NPV) of -١,١٦١,٠٢٢ د.م, an internal rate of return (IRR) of -٢%, and a payback period of — years.
| Indicator | Value |
|---|---|
| Initial Investment | ٣,٥٠٠,٠٠٠ د.م |
| First Year Revenue | ٢,١٠٠,٠٠٠ د.م |
| Annual Growth (CAGR) | ١٢% |
| Net Margin (Y1) | -٨% |
| Return on Investment (Avg.) | -١% annually |
| Net Present Value (NPV) | -١,١٦١,٠٢٢ د.م |
| Internal Rate of Return (IRR) | -٢% |
| Profitability Index (PI) | ١ |
| Payback Period | — |
| Break-even Year | — |
| Expected NPV (Probability Weighted) | -١,١٣٠,٣٧٥ د.م |
Assumptions and Basis
The figures in this study are based on project data, the nature of the medical and health sector in Morocco, and local market indicators, according to the following assumptions:
| Assumption | Value |
|---|---|
| Initial Capital | ٣,٥٠٠,٠٠٠ د.م |
| First Year Revenue | ٢,١٠٠,٠٠٠ د.م |
| Annual Growth | ١٢% |
| Cost of Goods Sold (COGS) | ٣٥% of Revenue |
| Operating Expenses | ٤٠% of Revenue |
| Tax/Zakat | ٥% |
| Discount Rate (WACC) | ١٢% |
| Study Horizon | ٥ years |
Project Description and Opportunity
The "Moroccan Drug Health" Platform (MediMorocco AI): An Integrated Smart System for Pharmaceutical Supply Chain Management and Monitoring in Morocco, Connecting Pharmaceutical Companies, Distributors, Pharmacies, and Hospitals offers clear value in the medical and health sector through a business model focused on a specific segment.
Market and Demand Study
Growing demand driven by changing behavior and spending.
Market Sizing (TAM / SAM / SOM)
| Level | Annual Size | Description |
|---|---|---|
| TAM — Total Addressable Market | ٠ د.م | Total serviceable demand |
| SAM — Serviceable Available Market | ٠ د.م | The portion reachable by your model |
| SOM — Serviceable Obtainable Market | ٠ د.م | Your realistic early share |
Competitive Analysis
Sustainable advantage through quality and brand.
Market Entry and Pricing Strategy
Digital and direct channels with competitive pricing.
Capacity and Operations
Operations with clear procedures and scalable capacity.
Projected Income Statement (5 Years)
| Item \ Year | Y1 | Y2 | Y3 | Y4 | Y5 |
|---|---|---|---|---|---|
| Revenues | ٢,١٠٠,٠٠٠ د.م | ٢,٣٥٢,٠٠٠ د.م | ٢,٦٣٤,٢٤٠ د.م | ٢,٩٥٠,٣٤٩ د.م | ٣,٣٠٤,٣٩١ د.م |
| Cost of Sales | (٧٣٥,٠٠٠ د.م) | (٨٢٣,٢٠٠ د.م) | (٩٢١,٩٨٤ د.م) | (١,٠٣٢,٦٢٢ د.م) | (١,١٥٦,٥٣٧ د.م) |
| Gross Profit | ١,٣٦٥,٠٠٠ د.م | ١,٥٢٨,٨٠٠ د.م | ١,٧١٢,٢٥٦ د.م | ١,٩١٧,٧٢٧ د.م | ٢,١٤٧,٨٥٤ د.م |
| Operating Expenses | (٨٤٠,٠٠٠ د.م) | (٩٤٠,٨٠٠ د.م) | (١,٠٥٣,٦٩٦ د.م) | (١,١٨٠,١٤٠ د.م) | (١,٣٢١,٧٥٦ د.م) |
| EBITDA | ٥٢٥,٠٠٠ د.م | ٥٨٨,٠٠٠ د.م | ٦٥٨,٥٦٠ د.م | ٧٣٧,٥٨٧ د.م | ٨٢٦,٠٩٨ د.م |
| Tax | (٠ د.م) | (٠ د.م) | (٠ د.م) | (١,٨٧٩ د.م) | (٦,٣٠٥ د.م) |
| Net Profit | -١٧٥,٠٠٠ د.م | -١١٢,٠٠٠ د.م | -٤١,٤٤٠ د.م | ٣٥,٧٠٨ د.م | ١١٩,٧٩٣ د.م |
| Net Margin | -٨% | -٥% | -٢% | ١% | ٤% |
Investment Cost Structure
| Item | Cost | Percentage |
|---|---|---|
| Equipment and Furnishing | ١,٢٢٥,٠٠٠ د.م | ٣٥% |
| Working Capital | ١,٠٥٠,٠٠٠ د.م | ٣٠% |
| Marketing and Launch | ٥٢٥,٠٠٠ د.م | ١٥% |
| Licenses and Establishment | ٤٢٠,٠٠٠ د.م | ١٢% |
| Contingency Reserve | ٢٨٠,٠٠٠ د.م | ٨% |
Cash Flow and Break-even Point
| Year | Operating Cash Flow | Cumulative Cash Flow |
|---|---|---|
| Year 1 | ٥٢٥,٠٠٠ د.م | -٢,٩٧٥,٠٠٠ د.م |
| Year 2 | ٥٨٨,٠٠٠ د.م | -٢,٣٨٧,٠٠٠ د.م |
| Year 3 | ٦٥٨,٥٦٠ د.م | -١,٧٢٨,٤٤٠ د.م |
| Year 4 | ٧٣٥,٧٠٨ د.م | -٩٩٢,٧٣٢ د.م |
| Year 5 | ٨١٩,٧٩٣ د.م | -١٧٢,٩٣٩ د.م |
Estimated break-even point at an annual revenue of ≈ ٢,٣٦٩,٢٣١ د.م (~١١٣% of first year revenue), with a ٦٥% contribution margin. Cumulative cash break-even beyond the study horizon.
Funding Structure
| Funding Source | Percentage | Amount |
|---|---|---|
| Equity | ٧٠% | ٢,٤٥٠,٠٠٠ د.م |
| Debt Financing (٨% interest) | ٣٠% | ١,٠٥٠,٠٠٠ د.م |
Sensitivity Analysis (Revenue × Operations)
Impact of simultaneous changes in revenue and costs on Net Present Value:
| Revenue \ Operations | −10% | −5% | Base | +5% | +10% |
|---|---|---|---|---|---|
| −20% | -٨٨٦,٧٣٥ د.م | -١,٢٥٢,٨٩٧ د.م | -١,٦٢٥,٠٠٠ د.م | -٢,٠٠٠,٠٠٠ د.م | -٢,٣٧٥,٠٠٠ د.م |
| −10% | -٥٧٠,٠٨٣ د.م | -٩٧٧,٦٧٢ د.م | -١,٣٩١,٨٥٩ د.م | -١,٨١٢,٥٠٠ د.م | -٢,٢٣٤,٣٧٥ د.م |
| Base | -٢٥٦,٦٤٥ د.م | -٧٠٥,٠٨٣ د.م | -١,١٦١,٠٢٢ د.م | -١,٦٢٥,٠٠٠ د.م | -٢,٠٩٣,٧٥٠ د.م |
| +10% | ٥٥,٠٧٤ د.م | -٤٣٥,٠٨٣ د.م | -٩٣٢,٢٠٣ د.م | -١,٤٣٨,٢٦٥ د.م | -١,٩٥٣,١٢٥ د.م |
| +20% | ٣٦٦,٧٩٢ د.م | -١٦٧,٥٨٣ د.م | -٧٠٥,٠٨٣ د.م | -١,٢٥٢,٨٩٧ د.م | -١,٨١٢,٥٠٠ د.م |
Scenario Analysis
| Scenario | Probability | NPV | Assessment |
|---|---|---|---|
| Pessimistic | ٢٥% | -١,٩٢٥,٠٠٠ د.م | Not feasible |
| Base | ٥٠% | -١,١٦١,٠٢٢ د.م | Not feasible |
| Optimistic | ٢٥% | -٢٧٤,٤٥٨ د.م | Not feasible |
Expected Present Value (Weighted): -١,١٣٠,٣٧٥ د.م.
Risk Analysis and Management
| Risk | Probability | Impact | Mitigation |
|---|---|---|---|
| Demand Volatility | Medium | Medium | Channel diversification |
| Cost Increase | Medium | High | Supply contracts |
| Competition | High | Medium | Brand differentiation |
Organizational Structure and Team
Core team with administrative, technical, and marketing competencies.
Legal and Regulatory Aspects
Completion of licenses and regulatory compliance in Morocco.
Expansion and Sustainability Plan
Geographic/product expansion after model validation.
Environmental, Social, and Governance (ESG) Impact
Resource optimization, job opportunities, and sustainable practices.
Conclusions and Recommendations
It is recommended to review pricing and cost structure before proceeding.
Sources and Disclaimer
- Estimates based on industry standards
Disclaimer: This is a guiding study that provides financial analysis according to approved industry standards; verify the figures locally according to your project's reality before any investment decision.
